KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Goodwill & Intangibles (2016 - 2025)

Astrazeneca (AZN) has 3 years of Goodwill & Intangibles data on record, last reported at $59.1 billion in Q4 2025.

  • For Q4 2025, Goodwill & Intangibles rose 1.52% year-over-year to $59.1 billion; the TTM value through Dec 2025 reached $59.1 billion, up 1.52%, while the annual FY2025 figure was $59.1 billion, 1.52% up from the prior year.
  • Goodwill & Intangibles reached $59.1 billion in Q4 2025 per AZN's latest filing, up from $58.2 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $59.1 billion in Q4 2025 and bottomed at -$32.6 billion in Q4 2023.
  • Average Goodwill & Intangibles over 3 years is $28.2 billion, with a median of $58.2 billion recorded in 2024.
  • Peak YoY movement for Goodwill & Intangibles: surged 278.65% in 2024, then increased 1.52% in 2025.
  • A 3-year view of Goodwill & Intangibles shows it stood at -$32.6 billion in 2023, then soared by 278.65% to $58.2 billion in 2024, then grew by 1.52% to $59.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $59.1 billion in Q4 2025, $58.2 billion in Q4 2024, and -$32.6 billion in Q4 2023.